MAGISTRA PHYSIO: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MAGISTRA PHYSIO
Largest movements
- Cash -€37,581
down €37,581 (-75.8%), from €49,569 to €11,987
mainly Net result for the year (-€21,285) and Other debts (-€15,965)
- Receivables within one year +€1,850
up €1,850 (+51.5%), from €3,591 to €5,441
of which Trade receivables: +€1,850
- Tangible fixed assets -€1,413
down €1,413 (-19.7%), from €7,157 to €5,743
- Profit (loss) carried forward -€21,285
down €21,285 (-392%), from -€5,427 to -€26,713
- Other debts -€15,965
down €15,965 (-58.7%), from €27,181 to €11,217
- Trade debts +€820
up €820 (+64.5%), from €1,270 to €2,090
- Gross operating margin -€14,451
down €14,451 (-346%), from -€4,180 to -€18,631
- Depreciation -€210
down €210 (-13.0%), from €1,624 to €1,413
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €61,462 | €24,502 | -€36,960 | -60.1% |
| Fixed assets | 21/28 | €7,247 | €5,833 | -€1,413 | -19.5% |
| Tangible fixed assets | 22/27 | €7,157 | €5,743 | -€1,413 | -19.7% |
| Other tangible fixed assets | 26 | €7,157 | €5,743 | -€1,413 | -19.7% |
| Financial fixed assets | 28 | €90 | €90 | = | 0.0% |
| Current assets | 29/58 | €54,215 | €18,669 | -€35,546 | -65.6% |
| Amounts receivable within one year | 40/41 | €3,591 | €5,441 | +€1,850 | +51.5% |
| Trade receivables | 40 | €840 | €2,690 | +€1,850 | +220% |
| Other amounts receivable | 41 | €2,751 | €2,751 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €49,569 | €11,987 | -€37,581 | -75.8% |
| Deferred charges and accrued income | 490/1 | €1,055 | €1,241 | +€185 | +17.6% |
| Total equity and liabilities | 10/49 | €61,462 | €24,502 | -€36,960 | -60.1% |
| Equity | 10/15 | €32,245 | €10,959 | -€21,285 | -66.0% |
| Contributions | 10/11 | €17,200 | €17,200 | = | 0.0% |
| Reserves | 13 | €20,472 | €20,472 | = | 0.0% |
| Distributable reserves | 133 | €20,472 | €20,472 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€5,427 | -€26,713 | -€21,285 | -392% |
| Amounts payable | 17/49 | €29,217 | €13,543 | -€15,674 | -53.6% |
| Amounts payable within one year | 42/48 | €29,217 | €13,543 | -€15,674 | -53.6% |
| Trade debts | 44 | €1,270 | €2,090 | +€820 | +64.5% |
| Suppliers | 440/4 | €1,270 | €2,090 | +€820 | +64.5% |
| Taxes, remuneration and social security | 45 | €765 | €236 | -€530 | -69.2% |
| Taxes | 450/3 | €765 | €236 | -€530 | -69.2% |
| Other amounts payable | 47/48 | €27,181 | €11,217 | -€15,965 | -58.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,624 | €1,413 | -€210 | -13.0% |
| Other operating charges | 640/8 | €682 | €761 | +€79 | +11.5% |
| Gross operating margin | 9900 | -€4,180 | -€18,631 | -€14,451 | -346% |
| Operating profit (loss) | 9901 | -€6,486 | -€20,805 | -€14,319 | -221% |
| Financial income | 75/76B | €119 | €138 | +€19 | +16.1% |
| Recurring financial income | 75 | €119 | €138 | +€19 | +16.1% |
| Financial charges | 65/66B | €345 | €342 | -€3 | -0.9% |
| Recurring financial charges | 65 | €345 | €342 | -€3 | -0.9% |
| Profit (loss) for the period before taxes | 9903 | -€6,712 | -€21,008 | -€14,297 | -213% |
| Income taxes | 67/77 | €249 | €277 | +€28 | +11.3% |
| Profit (loss) for the period | 9904 | -€6,960 | -€21,285 | -€14,325 | -206% |
| Profit (loss) for the period to be appropriated | 9905 | -€6,960 | -€21,285 | -€14,325 | -206% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 17 October 2026 via checked.be.